Precigen(PGEN.US)

Last Updated 19:00:00 ET
longbridge loading

How Surging PAPZIMEOS Revenue And Narrower Losses At Precigen (PGEN) Have Changed Its Investment Story

Simplywall·
US
PGEN
+3.61%
US
SBIO
+2.76%
US
FBT
+1.23%
Simplywall·
US
PGEN
+3.61%
US
SBIO
+2.76%
US
FBT
+1.23%

Transcript: Bionano Genomics Q1 2026 Earnings Conference Call

Fidelity·
US
BNGO
+1.71%
US
BIB
+3.26%
US
IHI
+0.46%
Fidelity·
US
BNGO
+1.71%
US
BIB
+3.26%
US
IHI
+0.46%

Precigen shares are trading higher after the company reported Q1 sales results.

benzinga_article·
US
PGEN
+3.61%
US
IBBQ
+1.65%
US
BBH
+0.22%
benzinga_article·
US
PGEN
+3.61%
US
IBBQ
+1.65%
US
BBH
+0.22%

Precigen | 8-K: FY2026 Q1 Revenue Beats Estimate at USD 23.25 M

Earnings Watch·
US
PGEN
+3.61%
Earnings Watch·
US
PGEN
+3.61%

Xtant Medical Reports First Quarter 2026 Financial Results | XTNT Stock News

StockTitan·
US
XTNT
+3.59%
StockTitan·
US
XTNT
+3.59%

Precigen to Announce First Quarter 2026 Financial Results and Provide Business Updates on May 13

Unusual Whales·
US
PGEN
+3.61%
US
IBB
+1.80%
US
FBT
+1.23%
Unusual Whales·
US
PGEN
+3.61%
US
IBB
+1.80%
US
FBT
+1.23%

3 Growth Companies With Insider Ownership Up To 12%

Simplywall·
US
UPST
+2.99%
US
PGEN
+3.61%
US
MNTN
-0.68%
Simplywall·
US
UPST
+2.99%
US
PGEN
+3.61%
US
MNTN
-0.68%

A Look At Precigen (PGEN) Valuation As PAPZIMEOS Commercial Launch And J Code Spark Investor Interest

Simplywall·
US
PGEN
+3.61%
US
LABU
+10.25%
US
BBH
+0.22%
Simplywall·
US
PGEN
+3.61%
US
LABU
+10.25%
US
BBH
+0.22%
© 2026 Longbridge｜Disclaimer